Taylor Wessing's patent dispute practice builds on two central pillars: technology, which includes IT, electronics and automotive, as well as life sciences, which includes pharmaceuticals, medical devices and biotechnology. The firm represents clients before German and international courts, including the UPC, and benefits from the firm's strengths in the US and Asia. Gisbert Hohagen heads the practice and focuses on patent, utility model and employee law, while regularly assisting with patent infringement, opposition and nullity proceedings. Standard essential patents are a central focus for Dietrich Kamlah, who, alongside dispute resolution, also frequently advises on contracts and transaction-related IP matters. Sabine Rojahn left the firm in December 2023.
Legal 500 Editorial commentary
- Profile
- Social
Key clients
- Abbott Laboratories
- Allison GmbH und Bright Children’s Products Ltd. (“BPC”) (beide Wonderland Group)
- Exertis
- Pfizer Inc.
- Mylan / Viatris
- Glenmark Pharmaceuticals Europe Ltd.; Glenmark Arzneimittel GmbH
- Hanshow Technology
- Realme
- Revolt Zycling AG
- Tandem Diabetes Care Europe B.V., Tandem Diabetes Care, Inc.
Work highlights
Representation of Pfizer Inc. in patent infringement proceedings brought by Moderna for alleged infringement of mRNA vaccine patents (Comirnaty) and damages claims based thereon.
Representation of Abbott Laboratories against infringement claims brought by Dexcom Inc. concerning continuous glucose monitoring as well as representation in other parallel proceedings in Paris, Munich, Hamburg and before UPC in local chambers in Munich and Düsseldorf.
Representation of Hanshow and its European subsidiaries before the UPC (Local Chamber of Munich) for alleged patent infringement by electronic shelf labels (ESL).
Lawyers
Practice head
Gisbert Hohagen
Other key lawyers
Dietrich Kamlah; Roland Küppers; Anja Lunze; Christoph de Coster; Philipp Krusemarck; Christian Lederer; Nora Wessendorf; Michael Schächinger; Alexander Rubusch; Jan Phillip Rektorschek